Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Arnold

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of the American Osteopathic Association|November 27, 2018
Bullous DiabeticorumLisa Arnold, Kaitlyn C Vennard, Matthew P Gilbert
Dermatologie (Heidelberg, Germany)|June 27, 2024
[Prurigo pigmentosa: Case report of a German adolescent]Lisa Arnold, Brigitte Coras-Stepanek, Ulrike Weigert, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 31, 2025
Screening for Borna disease virus 1 (BoDV-1) in Austria: Absence of human cases in a retrospective case-finding studyMarkus Bauswein, Lisa Arnold, David N Springer, et al.
BMC Neurology|September 28, 2018
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findingsMarwan N Sabbagh, Jiong Shi, Moonhee Lee, et al.
Immunotherapy|September 9, 2025
Successful treatment of localized Merkel cell carcinoma with avelumab in a patient with amyotrophic lateral sclerosisLisa Arnold, Dirk Tomsitz, Raquel Buchillon, et al.
Cancers|June 13, 2025
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 InhibitorsLisa Arnold, Monika Morak, Nora Kramer, et al.
Journal for Immunotherapy of Cancer|September 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitisKim Nikola Oliva, Lisa Arnold, Lucie Heinzerling, et al.
Signal Transduction and Targeted Therapy|February 25, 2026
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosisBhavika B Katariya, Shashipavan Chillappagari, Lisa Arnold, et al.
The Lancet Regional Health. Europe|July 18, 2025
Management of non-traumatic abdominal pain in the emergency department: a multicentre, stepped-wedge, cluster-randomised trialAnna Slagman, Liane Schenk, Dörte Huscher, et al.
Frontiers in Immunology|January 28, 2026
SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusionClara L Magnus, Zeliha Hamed Jaber, Andreas Hiergeist, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of the American Osteopathic Association|November 27, 2018
Bullous DiabeticorumLisa Arnold, Kaitlyn C Vennard, Matthew P Gilbert
Dermatologie (Heidelberg, Germany)|June 27, 2024
[Prurigo pigmentosa: Case report of a German adolescent]Lisa Arnold, Brigitte Coras-Stepanek, Ulrike Weigert, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 31, 2025
Screening for Borna disease virus 1 (BoDV-1) in Austria: Absence of human cases in a retrospective case-finding studyMarkus Bauswein, Lisa Arnold, David N Springer, et al.
BMC Neurology|September 28, 2018
Salivary beta amyloid protein levels are detectable and differentiate patients with Alzheimer's disease dementia from normal controls: preliminary findingsMarwan N Sabbagh, Jiong Shi, Moonhee Lee, et al.
Immunotherapy|September 9, 2025
Successful treatment of localized Merkel cell carcinoma with avelumab in a patient with amyotrophic lateral sclerosisLisa Arnold, Dirk Tomsitz, Raquel Buchillon, et al.
Cancers|June 13, 2025
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 InhibitorsLisa Arnold, Monika Morak, Nora Kramer, et al.
Journal for Immunotherapy of Cancer|September 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitisKim Nikola Oliva, Lisa Arnold, Lucie Heinzerling, et al.
Signal Transduction and Targeted Therapy|February 25, 2026
Targeting fused in sarcoma (FUS): a novel antisense strategy for treating idiopathic pulmonary fibrosisBhavika B Katariya, Shashipavan Chillappagari, Lisa Arnold, et al.
The Lancet Regional Health. Europe|July 18, 2025
Management of non-traumatic abdominal pain in the emergency department: a multicentre, stepped-wedge, cluster-randomised trialAnna Slagman, Liane Schenk, Dörte Huscher, et al.
Frontiers in Immunology|January 28, 2026
SARS-CoV-2 evolution enhances endocytic uptake while preserving TMPRSS2-dependent fusionClara L Magnus, Zeliha Hamed Jaber, Andreas Hiergeist, et al.
Pageof 2